Burnout BURNOUT

What Vaping Does to Your Lungs: The Science Explained

By Zigmars Dzerve · Apr 15, 2026 · 7 min read · Medically reviewed

Your lungs evolved to process air. Not aerosolized propylene glycol, not vaporized flavorings, not ultrafine metal particles. This isn't a moral judgment — it's a mechanical one. The respiratory system has specific defense mechanisms, and vaping engages and overwhelms several of them in ways that are now increasingly well-documented.

Here's what the research actually shows, separated from both industry downplaying and tabloid panic.

The Aerosol Is Not "Just Water Vapor"

This misconception persists, and it's worth putting down firmly. E-cigarette aerosol is a suspension of ultrafine liquid droplets containing propylene glycol (PG), vegetable glycerin (VG), nicotine, flavoring chemicals, and — depending on the device — trace metals from the heating coil. It is not steam. It is not water vapor. The particle size, chemical composition, and biological effects are fundamentally different from water vapor.

Ultrafine Particle Deposition

E-cigarette aerosol contains particles predominantly in the 100-200 nanometer range, classifying them as ultrafine particles (UFPs). Particles this small bypass the upper airway's filtration mechanisms — the nose, throat, and large bronchi — and deposit deep in the alveoli, where gas exchange occurs.

Research published in Respiratory Research using computational fluid dynamics modeling has shown that vaping deposits particles in the deep lung at rates comparable to or exceeding cigarette smoke, depending on device settings and puffing patterns. High-power sub-ohm devices produce particularly deep deposition due to both particle size distribution and the large volumes of aerosol generated per puff.

Once deposited, these particles interact with the thin alveolar epithelium and the surfactant layer that keeps alveoli from collapsing. Animal studies have demonstrated that chronic exposure to e-cigarette aerosol disrupts surfactant function and triggers inflammatory responses in alveolar macrophages — the immune cells responsible for clearing particulate matter from the lungs.

Flavoring Chemical Toxicity

The flavoring compounds in e-liquids are generally recognized as safe (GRAS) for ingestion. The digestive system handles them without issue. But GRAS status for ingestion says nothing about inhalation safety, and the lungs are far more vulnerable to chemical injury than the gut.

Diacetyl, the chemical responsible for buttery flavors, causes bronchiolitis obliterans (colloquially "popcorn lung") when inhaled occupationally at high concentrations. While many e-liquid manufacturers have removed diacetyl, related compounds — 2,3-pentanedione and acetoin — remain common and carry similar concerns. A 2015 study in Environmental Health Perspectives found diacetyl or related compounds in 92% of flavored e-liquids tested.

The concentrations in vaping are lower than those that caused occupational disease in popcorn factory workers. Whether chronic low-level inhalation produces subclinical airway damage is an active area of research, but the precautionary principle applies: these are chemicals with known inhalation toxicity being voluntarily inhaled daily. We cover the full context of this risk in our article on the popcorn lung and vaping myth.

Cinnamaldehyde

Cinnamaldehyde, the primary flavoring in cinnamon-flavored e-liquids, is directly cytotoxic to bronchial epithelial cells at concentrations found in commercial e-liquids. In vitro studies published in Toxicology in Vitro showed that cinnamaldehyde impairs ciliary function — the beating motion of tiny hair-like structures that move mucus and trapped particles up and out of the airways. Impaired ciliary function means reduced mucociliary clearance, which means particles, pathogens, and debris stay in the lungs longer.

Vanillin and Other Aldehydes

Vanilla, fruit, and candy flavors often rely on aldehyde compounds. When heated, some of these form new chemical species not present in the original liquid. Studies using gas chromatography-mass spectrometry have identified formaldehyde, acrolein, and acetaldehyde in e-cigarette aerosol — all known respiratory irritants, and formaldehyde is classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC). Concentrations vary substantially by device power and coil temperature, with higher-wattage devices generally producing more thermal degradation products.

Propylene Glycol and Vegetable Glycerin Effects

PG and VG form the base of nearly all e-liquids. Both are hygroscopic — they absorb water. When inhaled as aerosol, they draw moisture from airway surfaces.

Chronic PG inhalation has been studied in occupational settings (theatrical fog machines use PG-based fluid). Research on entertainment industry workers found increased rates of respiratory symptoms including chest tightness, wheezing, and reduced lung function with chronic exposure. These are among the many side effects of vaping that users frequently report. A study published in the American Journal of Industrial Medicine reported that chronic occupational PG mist exposure was associated with reduced FEV1 (forced expiratory volume) and increased airway responsiveness.

VG is thicker and produces denser aerosol. While less irritating than PG acutely, the sheer volume of aerosol produced by VG-heavy liquids in sub-ohm devices increases total particle deposition in the lungs.

Heavy Metals from Heating Coils

The coil that heats e-liquid is typically made from nichrome (nickel-chromium alloy), kanthal (iron-chromium-aluminum), or stainless steel. As coils heat and degrade, metal particles leach into the aerosol.

Studies published in Environmental Health Perspectives detected lead, nickel, chromium, and manganese in e-cigarette aerosol at levels exceeding occupational safety limits in some cases. Nickel and chromium are established carcinogens when inhaled. The concentrations increase as coils age, particularly when coils are used beyond their intended lifespan — which is common among vapers trying to save money.

Lead, even at low levels, has no safe threshold for exposure. Its presence in inhaled aerosol is a concern independent of concentration.

EVALI: What It Was and What It Wasn't

The 2019-2020 outbreak of E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) caused 2,807 hospitalizations and 68 deaths in the US. The cause was identified as vitamin E acetate, a thickening agent used in illicit THC vape cartridges.

This distinction matters. EVALI was not caused by commercial nicotine e-cigarettes. It was caused by a specific adulterant in unregulated THC products. Vitamin E acetate is an oil, and lipoid pneumonia — the inflammatory lung condition it triggers — is a fundamentally different pathology from the chronic airway effects of nicotine vaping.

However, EVALI illustrated an important broader point: when you inhale an aerosol, you're trusting that every ingredient in that liquid is safe for pulmonary exposure. The regulatory framework for e-liquids remains inconsistent, and independent testing has found discrepancies between labeled and actual contents in both nicotine levels and flavoring compositions.

What Imaging Studies Show

CT imaging studies of otherwise healthy young vapers have revealed subclinical findings that weren't expected. Research published in Radiology found that even asymptomatic vapers showed evidence of:

  • Air trapping on expiratory CT scans, indicating early small airway obstruction
  • Ground-glass opacities in some cases, suggesting alveolar inflammation
  • Bronchial wall thickening, consistent with chronic airway irritation

These findings don't mean every vaper has visible lung damage. They mean that detectable changes can occur before symptoms appear, and that normal-feeling lungs are not necessarily undamaged lungs.

Spirometry studies (breathing tests) have shown more mixed results. Some studies find reduced FEV1 in vapers compared to non-users, while others find no significant difference. The discrepancy likely reflects differences in device types, usage intensity, duration of use, and study population characteristics.

The Recovery Question

The good news: the lungs have substantial regenerative capacity. Much of the inflammatory response to vaping appears to be reversible with cessation. Ciliary function begins recovering within days to weeks. Inflammatory markers in bronchoalveolar lavage fluid decrease. Airway reactivity normalizes. For a detailed breakdown of what improves and when, see the quit vaping recovery timeline.

What's less clear is whether long-term, heavy vaping produces irreversible structural changes — fibrosis, permanent small airway remodeling, or emphysematous changes. The technology hasn't existed long enough for 20- or 30-year follow-up data. This is the core uncertainty, and it's intellectually honest to name it rather than pretend we know the full picture.

FAQ

Is vaping worse for your lungs than smoking?

Almost certainly not on a per-year basis. Cigarette smoke contains over 7,000 chemicals, including dozens of known carcinogens, tar, and carbon monoxide. Vaping eliminates combustion, which removes the most dangerous elements. But "less harmful than smoking" is not the same as "safe," and the long-term effects of chronic vaping are not yet fully characterized. We explore the full range of known risks in is vaping bad for you.

Can vaping cause popcorn lung?

The risk appears low with current formulations, as most manufacturers have reduced or eliminated diacetyl. However, related diketone compounds remain in many flavored e-liquids. No confirmed cases of bronchiolitis obliterans have been directly attributed to e-cigarette use in published medical literature, but subclinical airway effects from these compounds remain a concern.

How long does it take for lungs to heal after quitting vaping?

Inflammatory markers begin improving within weeks. Ciliary function recovers substantially within 1-9 months. Full recovery timelines depend on duration and intensity of use. Most former vapers report improved breathing within 1-3 months of cessation.

Does vaping cause lung cancer?

There is no direct evidence yet that vaping causes lung cancer in humans. However, e-cigarette aerosol contains known carcinogens (formaldehyde, nickel, chromium) at low levels, and animal studies have shown DNA damage in lung tissue exposed to e-cigarette aerosol. The latency period for lung cancer is typically 15-30 years, and widespread vaping is roughly a decade old, so absence of evidence is not evidence of absence.

Is secondhand vape aerosol harmful?

Exhaled e-cigarette aerosol contains ultrafine particles, nicotine, and flavoring chemicals at reduced but measurable concentrations. Indoor air quality studies show that vaping indoors increases particulate matter and nicotine levels. The health significance of bystander exposure is not well-established but is unlikely to be zero, particularly for vulnerable populations like children and people with respiratory conditions.

Continue reading

← All vaping articles